A fully automated IIF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies

被引：0
作者：
O. Shovman
N. Agmon-Levin
B. Gilburd
T. Martins
A. Petzold
T. Matthias
Y. Shoenfeld
机构：
[1] Zabludowitz Center for Autoimmune Diseases Sheba Medical Center,Sackler Faculty of Medicine
[2] Tel-Aviv University,Incumbent of the Laura Schwarz
[3] AESKU.DIAGNOSTICS,Kipp Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine
[4] Tel-Aviv University,undefined
来源：
Immunologic Research | 2015年 / 61卷
关键词：
Antinuclear antibodies; Antineutrophil cytoplasmic antibodies; Indirect immunofluorescence; Automation; Autoantibodies; Autoimmunity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Indirect immunofluorescence (IIF) is the main technique for the detection of antinuclear antibodies (ANA) and antineutrophil cytoplasmic antibodies (ANCA). The fully automated IIF processor HELIOS® is the first IIF processor that is able to automatically prepare slides and perform automatic reading. The objective of the present study was to determine the diagnostic performance of this system for ANA and ANCA IIF interpretation, in comparison with visual IIF. ANA detection by visual IIF or HELIOS® was performed on 425 sera samples including: 218 consecutive samples submitted to a reference laboratory for routine ANA testing, 137 samples from healthy subjects and 70 ANA/ENA positive samples. For ANCA determination, 170 sera samples were collected: 40 samples for routine testing, 90 samples from healthy blood donors and 40 anti-PR3/anti-MPO positive subjects. Good correlation was found for the visual and automated ANA IIF approach regarding positive/negative discrimination of these samples (kappa = 0.633 for ANA positive samples and kappa = 0.657 for ANA negative samples, respectively). Positive/negative IIF ANCA discrimination by HELIOS® and visual IIF revealed a complete agreement of 100 % in sera from healthy patients and PR3/MPO positive samples (kappa = 1.00). There was 95 % agreement between the ANCA IIF performed by automated and visual IIF on the investigation of routine samples. Based on these results, HELIOS® demonstrated a high diagnostic performance for the automated ANA and ANCA IIF interpretation that was similar to a visual reading in all groups of samples.
引用
收藏
页码：135 / 140
页数：5
相关论文
共 58 条
[1]  
Agmon-Levin N(2014)Response to: ‘detection of antinuclear antibodies—added-value of solid phase assay?’ by Bossuyt and Fieuws Ann Rheum Dis 73 e11-620
[2]  
Damoiseaux J(2008)Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes Autoimmun Rev 7 616-324
[3]  
Shoenfeld Y(2002)Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases Am J Clin Pathol 117 316-1422
[4]  
Fritzler MJ(2010)ANA screening: an old test with new recommendations” Ann Rheum Dis 69 1420-197
[5]  
Tozzoli R(2006)Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum J Immunol Methods 311 189-294
[6]  
Bizzaro N(2005)Determination of ANA specificity using the UltraPlex platform Ann NY Acad Sci 1050 286-442
[7]  
Tonutti E(2010)PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis J Autoimmun 35 436-286
[8]  
Meroni PL(1993)Anti-neutrophil cytoplasmic autoantibodies (ANCA): antigenic specificities and clinical associations Adv Exp Med Biol 14 281-513
[9]  
Schur PH(1999)International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA) Am J Clin Pathol 14 507-1286
[10]  
Nifli AP(2006)Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing Clin Chem Lab Med 14 1283-1317
123456